Investment
Features
FeesSafety
Academy
More
Pluang+

Western Asset High Income Fund II's attractive yield masks risks of NAV erosion and overdistribution.

Market News
26 Aug 2026
Seeking Alpha
View Source
Bearish
Western Asset High Income Fund II's attractive yield masks risks of NAV erosion and overdistribution.

Western Asset High Income Fund II (HIX) is a leveraged closed-end fund with a global fixed income portfolio offering a high distribution yield. However, its yield is not covered by net investment income, causing ongoing net asset value (NAV) erosion and concerns about overdistribution. The fund's discount has narrowed recently, reducing its valuation appeal compared to historical levels, which may make it less attractive to investors. This analysis highlights the trade-offs between yield and risk in HIX's investment profile.

More News

Constellation Brands beats earnings and revenue estimates with strong beer and spirits sales.

Constellation Brands beats earnings and revenue estimates with strong beer and spirits sales.

Constellation Brands reported earnings per share of $3.74, surpassing analyst estimates of $3.55, and revenue of $2.63 billion, exceeding the $2.54 billion forecast. The company saw a 5% increase in beer sales and a 17% rise in wine and spirits sales...

Company Fundamentals
Bullish
4 hours ago
U.S. spot Solana ETFs see $3.7M outflows on Oct 6, continuing a recent withdrawal trend.

U.S. spot Solana ETFs see $3.7M outflows on Oct 6, continuing a recent withdrawal trend.

U.S. spot Solana ETFs experienced $3.7 million in net outflows on October 6, marking the second consecutive day of withdrawals. The Grayscale Solana Trust was the main contributor to this decline, while six other funds showed no net flow. Although th...

Market News
Bearish
4 hours ago
Tilray Brands to report Q1 2027 results with expected revenue growth and ongoing losses

Tilray Brands to report Q1 2027 results with expected revenue growth and ongoing losses

Tilray Brands will announce its fiscal Q1 2027 earnings on October 8, with analysts forecasting a loss of $0.16-$0.19 per share on revenues around $265-$268 million, marking about 26% growth from last year. Investors will focus on cannabis and bevera...

Company Fundamentals
Neutral
4 hours ago
Five stocks jump 21%-53% on news of acquisitions, blockchain, AI, and federal financing.

Five stocks jump 21%-53% on news of acquisitions, blockchain, AI, and federal financing.

On October 6, 2026, five notable stocks surged between 20.9% and 52.7%, driven by various positive developments. Apimeds Pharmaceuticals rose 52.7% after its subsidiary signed a blockchain contract, while Option Care Health gained 32.7% following a $...

Market News
Bullish
4 hours ago
Five stocks drop sharply on Oct 6, led by ArriVent BioPharma after lung cancer drug trial failure.

Five stocks drop sharply on Oct 6, led by ArriVent BioPharma after lung cancer drug trial failure.

On October 6, five notable stocks saw significant declines, with losses ranging from 17.5% to 50.1%. ArriVent BioPharma's shares plunged 46.9% after its lung cancer treatment failed to meet the primary endpoint in a Phase 3 trial. Armada Acquisition ...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App